Key result
Human WIP functions in yeast to link the polarity development pathway and the actin cytoskeleton, suppressing growth and cytoskeletal defects in vrp1-1 mutant cells.
Human WIP functions as a functional homologue to yeast verprolin, linking the polarity development pathway and actin cytoskeleton, providing insights into immunodeficiencies like Wiskott-Aldrich syndrome.
Answers are grounded in this paper and cite their sources.
Should not change immunodeficiency management; leaves open whether WIP homology informs human disease mechanisms or therapies.
WIP, the Wiskott-Aldrich syndrome protein-interacting protein, is a human protein involved in actin polymerization and redistribution in lymphoid cells. The mechanism by which WIP reorganizes actin cytoskeleton is unknown. WIP is similar to yeast verprolin, an actin- and myosin-interacting protein required for polarized morphogenesis. To determine whether WIP and verprolin are functional homologues, we analyzed the function of WIP in yeast. WIP suppresses the growth defects of VRP1 missense and null mutations as well as the defects in cytoskeletal organization and endocytosis observed in vrp1-1 cells. The ability of WIP to replace verprolin is dependent on its WH2 actin binding domain and a putative profilin binding domain. Immunofluorescence localization of WIP in yeast cells reveals a pattern consistent with its function at the cortical sites of growth. Thus, like verprolin, WIP functions in yeast to link the polarity development pathway and the actin cytoskeleton to generate cytoskeletal asymmetry. A role for WIP in cell polarity provides a framework for unifying, under a common paradigm, distinct molecular defects associated with immunodeficiencies like Wiskott-Aldrich syndrome.
No takes yet. Share an insight, caveat, or question.
Vaduva et al. (1999) studied this question. Human WIP (Wiskott-Aldrich syndrome protein-interacting protein) was evaluated on Suppression of growth defects and cytoskeletal organization/endocytosis defects. Human WIP functions in yeast to link the polarity development pathway and the actin cytoskeleton, suppressing growth and cytoskeletal defects in vrp1-1 mutant cells.
Synapse has enriched 10 related papers. Consider them for comparative context: